SUBSCRIBE
SUBSCRIBE

Massachusetts

Job Trends
Massachusetts’ Life Sciences Job Growth Slows, but 10-Year Outlook Remains Strong: Report
Although Massachusetts’ life sciences job growth increased by just 2.5% in 2023, the state continues to grow the industry, according to a new MassBioEd report.
June 12, 2024
 · 
4 min read
 · 
Angela Gabriel
Load More
PRESS RELEASES
Press Releases
NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million
May 24, 2026
 · 
11 min read
Press Releases
PharmaEssentia to Present New Clinical Data Supporting the Use of Ropeginterferon Alfa-2b in Essential Thrombocythemia at ASCO and EHA 2026
May 24, 2026
 · 
9 min read
Press Releases
Vicore Pharma Pursues US Dual Listing, Files Registration Statement with the SEC
May 24, 2026
 · 
5 min read
Press Releases
Agios’ PYRUKYND® (mitapivat) Approved in the European Union for Adults with Thalassemia
May 24, 2026
 · 
15 min read
Press Releases
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference 2026
May 24, 2026
 · 
1 min read
Press Releases
Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference
May 24, 2026
 · 
1 min read
Press Releases
Foundation Medicine Showcases Innovation at 2026 ASCO® Annual Meeting
May 22, 2026
 · 
6 min read
Press Releases
Zai Lab Announces Changes to Senior Leadership Team - May 21, 2026
May 22, 2026
 · 
4 min read
Press Releases
Agenus and Noetik Present ASCO 2026 Data Linking AI Analysis of Routine Pretreatment Tumor Pathology Images to Response and Survival with BOT+BAL in MSS Metastatic CRC
May 22, 2026
 · 
8 min read
Press Releases
Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting
May 22, 2026
 · 
10 min read
Press Releases
Agenus Presents Phase 2 BOT+BAL Melanoma Data Showing Durable Responses and Meaningful Survival in Advanced Checkpoint-Refractory Melanoma at ASCO 2026
May 22, 2026
 · 
9 min read
Press Releases
Obsidian Therapeutics to Present Phase 2 Clinical Data for OBX-115 in Advanced Melanoma in Oral Presentation at 2026 ASCO Annual Meeting
May 22, 2026
 · 
11 min read
Press Releases
Ingenia Therapeutics, a Clinical-Stage Biotechnology Company, Has Received Approval for an Initial Public Offering on the Korea Exchange (KRX)
May 22, 2026
 · 
6 min read
Press Releases
Convergent Therapeutics to Present Largest Set of Prospective Phase 2 Data for an Alpha Radiopharmaceutical in Lu-PSMA-Exposed Metastatic Castration-Resistant Prostate Cancer at ASCO 2026
May 22, 2026
 · 
5 min read
Press Releases
Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
May 22, 2026
 · 
15 min read
Press Releases
Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
May 22, 2026
 · 
8 min read
Press Releases
Accent Therapeutics to Present Trial in Progress Poster for Phase 1/2 Study of ATX-295 at the 2026 American Society of Clinical Oncology Annual Meeting
May 22, 2026
 · 
4 min read
Press Releases
Servier Presentations at ASCO 2026 Spotlight Expanding Rare Oncology Portfolio
May 22, 2026
 · 
10 min read
Press Releases
Rgenta Therapeutics Presents Positive Preliminary Data from Ongoing Phase 1a/b Clinical Trial of RGT-61159 in Patients with Adenoid Cystic Carcinoma and Colorectal Cancer at the 2026 ASCO Meeting
May 22, 2026
 · 
5 min read
Press Releases
Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC
May 22, 2026
 · 
13 min read
Load More